← All trials
NCT05031676
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 15, 2019
- Primary completion
- Jun 15, 2020
- Completion date
- Oct 5, 2020
- First posted
- Sep 2, 2021
- Last posted
- Sep 2, 2021
- Enrollment
- 66
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Université NAZI BONILead sponsor
- Université NAZI BONIReponsible party - principal investigator
- University of Joseph KI-ZERBOStudy chair
- University of Joseph KI-ZERBOStudy director
- Université NAZI BONIStudy director
- CHU Sanou Souro, Bobo-DioulassoOverall official - principal investigator
- CHU Sanou Souro, Bobo-DioulassoStudy chair
- CHU CharleroiStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.